Cure EB
VC Fund
London, United Kingdom
Cure EB is a nonprofit organization dedicated to funding research and accelerating the development of effective treatments and ultimately a cure for Epidermolysis Bullosa (EB), a rare and debilitating genetic skin disorder. The organization focuses on raising awareness, supporting scientific research, and collaborating with leading researchers,biotech companies, and healthcare professionals worldwide to advance promising therapies for EB.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cure EB invests in
Stages Cure EB invests in
Countries Cure EB invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
James Collins
|
|||
Sharmila Nikapota
|
|||
3 more contacts available
Investment Focus
Industry
- Biotechnology 2 (67%)
- Medical 1 (33%)
Stage
- Seed 1 (33%)
- Funding Round 1 (33%)
- Venture - Series Unknown 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
James Collins
Co-Founder and Trustee
|
Co-Founder and Trustee | Total investments: 0 | Find email | |
|
Sharmila Nikapota
Co-Founder and Trustee
|
Co-Founder and Trustee | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Healome Therapeutics
|
Healome Therapeutics | $2.7M / Seed / Jul 07, 2026 | |
Eliksa Therapeutics
|
Eliksa Therapeutics is a biotechnology company that develops regenerative medicine. | Oct 29, 2025 | |
Nova Anchora
|
Nova Anchora, a biopharmaceutical startup, is developing a corrected protein therapy for DEB, a severe uncommon skin disease. | Venture - Series Unknown / Apr 29, 2025 |
Co-Investors
DEBRA Research
3 deals together
EB Medical Research Foundation
2 deals together
EB Research Partnership
2 deals together
ABE
1 deal together
Empirical Ventures
1 deal together
Oshen
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cure EB invest in?
Cure EB invests primarily in Biotechnology and Medical startups, most often at Seed and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cure EB?
Public channels for Cure EB include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cure EB?
The team at Cure EB includes James Collins (Co-Founder and Trustee) and Sharmila Nikapota (Co-Founder and Trustee). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
